The expression level of caspase-3 appeared at 17 kDa which is cleaved caspase-3, and it was significantly elevated in the epilepsy group compared with the control group but decreased significantly after both sodium valproate and GAA treatments (p < 0.05, respectively, Figure 10). Here, CASP3 is linked to epilepsy.